Related by context. All words. (Click for frequent words.) 65 pharmacological approaches 64 non pharmacological interventions 64 cognitive behavioral therapies 63 psychopharmacological 63 nonpharmacological 63 guideline concordant 63 CAM therapies 62 homoeopathic remedies 62 nutrient supplementation 62 psychotherapies 61 antiplatelet medications 61 generalisability 61 allergen avoidance 60 topical NSAIDs 60 inhaled bronchodilators 60 pharmacogenetic testing 60 pharmacologic treatments 60 biologic DMARDs 60 pharmacological interventions 60 nonpharmacological treatments 60 pharmacological therapy 60 psychotherapeutic interventions 60 pharmacological therapies 60 methodologically rigorous 60 nonpharmacologic 60 dietary interventions 60 antiplatelet therapies 59 somatoform disorders 59 osteopathic manipulation 59 antiepileptics 58 Quantitative EEG 58 Herbal remedies 58 DVT PE 58 metaanalysis 58 antioxidant supplementation 58 probiotic supplementation 58 Homeopathic medicines 58 IBS sufferers 58 pharmacological treatments 58 meta cognitive 58 prescribers pharmacists 57 empiric therapy 57 biopsychosocial 57 HCPs 57 chemopreventive agents 57 rheumatic diseases 57 biologic plausibility 57 routine episiotomy 57 Naturopathic medicine 57 perinatal depression 57 biopsychosocial model 57 multivitamin supplements 57 integrative approaches 57 psychiatric comorbidities 57 Guided imagery 57 gynecologic procedures 57 pharmacological intervention 57 Systematic reviews 56 geriatric syndromes 56 diagnosing autism 56 developmental neurotoxicity 56 NUCYNTA R 56 Psychosocial interventions 56 Meta analyzes 56 Naturopathic doctors 56 anticonvulsant medications 56 acupuncture meditation 56 opioid prescribing 56 non selective NSAIDs 56 psychoeducation 56 diagnosing ADHD 56 pharmacotherapies 56 psychotherapeutic drugs 56 poststroke depression 56 nondrug treatments 56 integrative therapies 56 opioid misuse 56 lipid lowering medication 56 hormone therapy HT 56 pharmacologic approaches 56 analgesic medications 56 psychotherapeutic treatments 56 methodologic 56 opiate analgesics 56 nonphysician 56 primary dysmenorrhoea 56 ski lls 56 psychoneuroimmunology 56 mu opioid agonists 56 biphosphonates 56 genotype phenotype 56 pituitary disorders 55 anti androgens 55 psychodynamic therapy 55 lipid lowering agents 55 vertebral subluxation 55 pyridostigmine 55 melatonin supplements 55 oral NSAIDs 55 colorectal carcinogenesis 55 maladaptive behaviors 55 fusion enhancers 55 pharmacotherapeutic 55 LLLT 55 patient centeredness 55 Spinal manipulation 55 naturopathic remedies 55 GnRH agonists 55 intracranial stenosis 55 compounded bioidentical hormones 55 pharmacologic intervention 55 familial predisposition 55 ConclusionThis 55 neuropsychiatric symptoms 55 atypical antipsychotic medications 55 perioperative nurses 55 prescribed opioids 55 triptan therapy 55 STEP BD 55 generalisable 55 Monjan 55 APRNs 55 syndromic 55 antiangiogenic agents 55 pharmacologic interventions 55 endometriosis ovarian cysts 55 G. biloba 55 lung cancer chemoprevention 55 NCCN Compendium 55 statins cholesterol lowering 55 reducing sodium intake 55 thromboembolic disease 55 Herbal supplements 55 CSHCN 55 unproven remedies 55 osteopathic manipulative treatment 55 chiropractic acupuncture 55 hospice palliative 55 acupuncture hypnosis 55 psychosocial stressors 55 warfarin dosing 55 Comparative effectiveness 54 BEXXAR therapeutic regimen 54 testosterone supplementation 54 Therapeutic massage 54 Integrative medicine 54 dentin hypersensitivity 54 antithrombotic therapy 54 immunosuppressive therapies 54 causal inference 54 Geriatricians 54 nonadherence 54 etiological 54 heritable disorders 54 antifungal medications 54 methodological rigor 54 Emollients 54 NovaBay Aganocide compounds 54 constipation OIC 54 antihypertensive drugs 54 HighTower advisors 54 comorbid disorders 54 aldosterone antagonists 54 pathophysiologic mechanisms 54 anticoagulant warfarin 54 cognitive enhancers 54 functional gastrointestinal disorders 54 detecting diagnosing 54 differential gene expression 54 serotonin deficiency 54 multivitamin mineral supplement 54 Observational studies 54 pharmacogenetic tests 54 unmeasured confounding 54 Cognitive therapy 54 multicenter trials 54 Complementary therapies 54 RISPERDAL ® 54 antiemetics 54 GERD sufferers 54 hypochondriasis 54 psychopharmacologic 54 vitamins minerals herbal 54 somatostatin analogs 54 nurse practitioners NPs 54 biomedically 54 RCTs 54 anticholinergic agents 54 dissolving microneedles 54 topical microbicides 54 placebo controlled studies 54 pelvic examinations 54 Ear candling 54 neuropsychological impairments 54 SOCE 54 catheter ablations 54 antiplatelet drugs 54 dosing algorithm 54 thromboprophylaxis 54 inhaled glucocorticoids 54 iron supplementation 54 InfoScriber 54 medicine EBM 54 Randomised controlled trials 54 NUCYNTA ™ 54 TLR antagonists 54 GI motility disorders 54 dyslipidemias 54 pelvic girdle pain 54 ADME properties 54 biobehavioral 54 prenatal exposures 54 pathophysiological processes 54 homeopathy naturopathy 54 aldosterone antagonist 54 Zevalin consolidation 54 adaptogens 54 overactive bladder symptoms 53 steroid inhalers 53 pain syndromes 53 Multiple logistic regression 53 adjuvant therapies 53 APTIVUS ritonavir 53 methodologically sound 53 healing modalities 53 antipyretics 53 fluoxetine Prozac 53 sociocultural context 53 antidiabetic medications 53 EEG abnormalities 53 ophthalmology dermatology 53 sedating medications 53 gastroenterologists endocrinologists 53 non nutritive sweeteners 53 lipid lowering therapies 53 NPWH 53 rosacea sufferers 53 Regular checkups 53 meta analytic 53 venous thromboembolism VTE prophylaxis 53 acupuncture acupressure 53 comorbid conditions 53 DHEA supplementation 53 gotu kola 53 varenicline Chantix 53 nonsurgical treatments 53 trastuzumab Herceptin ® 53 prospective observational studies 53 preventer inhalers 53 neuropsychiatric diseases 53 Thyroid nodules 53 Genetic predisposition 53 methodological weaknesses 53 pharmacoeconomic 53 insomnia sufferers 53 Cognitive behavioral 53 antipsychotic prescribing 53 immunological mechanisms 53 noncognitive 53 ACCORD Lipid 53 methodological limitations 53 environmental toxicants 53 unmeasured factors 53 spinal manipulation 53 inhaled bronchodilator 53 coexisting disorders 53 HIV tropism 53 etiologic 53 Relaxation techniques 53 oncologic outcomes 53 glial tumors 53 physiologic mechanisms 53 medication nonadherence 53 hawthorn extract 53 sonographic diagnosis 53 CAM practitioners 53 lipid lowering medications 53 dyslipidaemia 53 cetirizine Zyrtec 53 NINR 53 empirically validated 53 fibrate drugs 53 neonatal circumcision 53 behavioral interventions 53 biological plausibility 53 Nutrient deficiencies 53 randomized controlled trials RCTs 53 cyclic HMB 53 Anti psychotics 53 meta analyzes 53 biologic pathways 53 interpersonal psychotherapy 53 SSRI antidepressants 53 nutrigenomic 53 CMHCs 53 antiplatelet agents 53 digestive disturbances 53 anti TNF biologic 53 familial clustering 53 PPCPs 53 HATE CPAP 53 Registered dietitians 53 orthomolecular 53 TF CBT 53 scientific substantiation 53 wounds ostomies 53 differential diagnoses 53 visit www.BYETTA.com 53 vitamin supplementation 53 herbal formulas 53 Vegetarian diets 53 vestibular rehabilitation 53 developmental trajectories 53 chronic periodontitis 53 physiological nutritional 53 Balloon sinuplasty 53 heritable diseases 53 SRIs 53 infantile colic 53 prostate carcinogenesis 53 BEXXAR Therapeutic Regimen 53 dietary modification 53 therapeutic regimens 53 Topical corticosteroids 53 neuromusculoskeletal 53 Accutane isotretinoin 53 intensive lipid lowering 53 chronic noncancer pain 53 incidentalomas 53 preventive promotive 53 prelicensure 53 Polypharmacy 53 anticholinergic effects 53 mechanistic pathways 52 teratogenic 52 physician extenders 52 subthreshold depression 52 somatic symptoms 52 lipid lowering drugs 52 antidepressive 52 tiagabine 52 Herbal medicines 52 renoprotective 52 NCCAM 52 IMPROVE HF 52 Cochrane reviewers 52 Dr. Kaminetsky 52 beta carotene supplementation 52 dermatologic surgeons 52 acupuncture homeopathy 52 psychiatrists neurologists 52 integrative oncology 52 Chronic Lyme disease 52 Disordered eating 52 etiological factors 52 Bach Flower Essences 52 convergent validity 52 immunosuppressive regimens 52 prophylactic anticoagulation 52 Liver toxicity 52 Professor Ussher 52 paraphilias 52 postmarket surveillance 52 osteopathic manipulative medicine 52 antenatal depression 52 prophylactic antibiotic 52 paroxetine Paxil 52 tumor subtype 52 chronic LBP 52 orofacial pain 52 nondrug approaches 52 neurocognitive functioning 52 epidural steroid injections 52 reflux symptoms 52 Systematic Reviews 52 individualize therapy 52 efficacy tolerability 52 neurobiological underpinnings 52 nocturnal enuresis 52 Yohimbine 52 hematopoietic malignancies 52 postmarketing surveillance 52 depressive illnesses 52 intranasal corticosteroids 52 antioxidant vitamin supplements 52 CYP#D# inhibitors 52 frameless radiosurgery 52 podiatric medical 52 smoking cessation therapies 52 topical anesthetics 52 Umbilical cord stem cells 52 herbal homeopathic 52 homoeopaths 52 CB1 antagonists 52 contra indications 52 Perforomist ™ Inhalation Solution 52 symptomatic fibroids 52 MTWA testing 52 topical calcineurin inhibitors 52 fermentable carbohydrates 52 Fortified foods 52 sirtuin activators 52 myopathy rhabdomyolysis 52 Hyperbaric Oxygen Therapy HBOT 52 Membrane proteins 52 selenium supplementation 52 Rigorous scientific 52 Predictive modeling 52 hypnosis acupuncture 52 opioid medications 52 psoriasis sufferers 52 stress reducers 52 SGAs 52 immunotherapeutic approaches 52 penile vaginal penetration 52 Dietary intakes 52 reversible contraceptive 52 herpes zoster vaccine 52 immune reconstitution syndrome 52 erythropoietic agents 52 ophthalmologists Eye MDs 52 intravenous bisphosphonates 52 VBID 52 micronutrient supplements 52 SPRIX ® 52 psychoeducational 52 ICD therapy 52 sociodemographic characteristics 52 multidisciplinary approach 52 relieving menopausal symptoms 52 Nonmedical 52 Tylenol acetaminophen 52 NCCN guidelines 52 rEEG 52 enterotypes 52 antidiabetic drugs 52 immunosuppressive agents 52 maladaptive coping 52 Premature menopause 52 swallowing disorders 52 rheumatic disorders 52 iPrEx study 52 disordered eating patterns 52 NHAMCS 52 procedural sedation 52 non sedating antihistamines 52 gabapentin Neurontin 52 empiric 52 observable behaviors 52 neurodevelopmental disabilities 52 antithrombotic agents 52 destigmatizing 52 conjoint analysis 52 heritable variation 52 commonly prescribed antidepressants 52 CVD cardiovascular disease 52 oral anticoagulation 52 Autism Spectrum Disorders ASDs 52 blinded randomized controlled 52 geriatric psychiatrists 52 generalizability 52 neuroleptic drugs 52 antibiotic prophylaxis 52 topical corticosteroids 52 tamoxifen Nolvadex ® 52 observational cohort 52 noscapine 52 simulated acupuncture 52 polysaccharide vaccines 52 Behavior modification 52 unconscious biases 52 therapy CBT 52 statin medications 52 intersexuality 52 psychotherapeutic 52 acupuncture reflexology 52 psychobiological 52 antipsychotics antidepressants 52 turmeric extract 52 CLBP 52 neurologic disorders 52 inactivated influenza vaccines 52 cardiometabolic risk 52 bodyworkers 52 podiatric physicians 52 insulin analogues 51 pharmacologic 51 Temporal lobe epilepsy 51 postexposure prophylaxis 51 antithrombotic therapies 51 oral antidiabetes drugs 51 chronic lyme 51 intensive statin therapy 51 KETEK 51 disordered eating behaviors 51 silent myocardial ischemia 51 ergogenic aids 51 antithrombotics 51 overdiagnose 51 topical retinoid 51 isoflavone supplement 51 POM Juice 51 comorbid diagnoses 51 Strengths Near 51 photoaging 51 nocebo 51 dietary antioxidants 51 INVEGA ® 51 Heavy menstrual bleeding 51 newer atypical antipsychotics 51 Bergenstal 51 diovan 51 atypical femur fractures 51 esophageal reflux 51 nonmedically 51 nonpharmaceutical 51 multimodal analgesia 51 electro acupuncture 51 topical antibiotics 51 pathogenic mechanisms 51 neural substrates 51 COIs 51 intranasal steroids 51 psychosocial variables 51 venlafaxine Effexor 51 molecularly targeted therapies 51 Benzoyl peroxide 51 degenerative neurological diseases 51 psychoactive medications 51 gynecological diseases 51 pediatric rheumatologists 51 ADVEXIN therapy 51 Mood stabilizers 51 nonpharmaceutical interventions 51 androgen depletion therapy 51 natural progesterone creams 51 prescription dermatological 51 HANDS Protocols 51 Informed consent 51 Triptans 51 refore 51 genetic susceptibilities 51 dentinal hypersensitivity 51 thiopurine 51 Secondary efficacy endpoints 51 homeopathy acupuncture 51 acetylcholinesterase inhibitors 51 complementary therapies 51 metacognition 51 noncognitive skills 51 ovulation induction 51 distributional consequences 51 nasal irrigation 51 meta regression 51 Venous thromboembolism 51 Dyspepsia Tachycardia Myalgia etc. 51 EEG biofeedback 51 therapies 51 Healia Communities 51 Subgroup analyzes 51 bioidentical estrogen 51 antidepression 51 Mechanistic studies 51 PHY# [002] 51 allergen immunotherapy 51 pharmacological 51 postoperative AF 51 TNF alpha inhibitor 51 subclinical disease 51 bioinformatic approaches 51 Colorectal cancer screening 51 GBS colonization 51 diagnosing bipolar disorder 51 antidiabetic agents 51 bendroflumethiazide 51 noncancer pain 51 Placebos 51 Goldbeck Wood 51 methodological approaches 51 Option IVC Filter 51 unnecessary cesareans 51 anticholinergic drugs 51 riociguat 51 routine neonatal circumcision 51 adjunctively 51 Thyroid disorders 51 subgroup analyzes 51 sexual dysfunctions 51 paternal discrepancy 51 Homeopathic remedies 51 NATRECOR ® 51 ketogenic diets 51 Pneumococcal vaccination 51 clinicians 51 Lactation consultants 51 biochemical abnormalities 51 serotonin reuptake inhibitors 51 comorbid depression 51 leukotriene receptor antagonists 51 atypicals 51 bioidenticals 51 folate supplementation 51 cranial osteopathy 51 postmenopausal hormone replacement 51 homeopathic treatments 51 unruptured aneurysm 51 hemorrhoid treatments 51 spinal manipulative 51 Suicidal tendencies 51 hypoxic tumors 51 dapsone 51 laparoscopic bariatric surgery 51 psychostimulants 51 nasal allergy symptoms 51 protease inhibitor PI 51 Lactobacillus GG 51 MMP inhibitors 51 lipid parameters 51 comorbid psychiatric disorders 51 multimodality imaging 51 psychopathologies 51 chiropractic acupuncture massage 51 neuropsychological assessment 51 underdiagnosis 51 orthomolecular medicine 51 adrenal suppression 51 chiropractic manipulation 51 allogeneic HSCT 51 serosorting 51 USPSTF recommendations 51 strapless organza pleated gown 51 dermatologic diseases 51 similars 51 antiandrogens 51 circadian rhythm disorders 51 aromatase inhibitors AIs 51 DTCA 51 Calorie restriction 51 chiropractors osteopaths 51 Ketotransdel TM 51 breast endometrial 51 interpersonal psychotherapy IPT 51 ovulatory cycles 51 atherothrombotic 51 guggul 51 CLDs 51 internalizing disorders 51 glucose abnormalities 51 nonallergic rhinitis 51 unmeasured confounders 51 potentially modifiable 51 Archimedes Model 51 antiresorptive 51 neurobiological basis 51 newer antipsychotic medications 51 undertreatment 51 premenstrual syndrome PMS 51 mixed hyperlipidemia 51 Insect repellants 51 oral antihistamines 51 poor metabolizers 51 antirheumatic 51 Sociodemographic 51 regular dental checkups 51 AAO HNS 51 reversible contraception 51 LHRH antagonists 51 intrathecal baclofen 51 Warfarin Coumadin 51 anti angiogenic drugs 51 placebo controlled trials 51 inhaled nitric oxide 51 salicylates 51 pharmacotherapeutics 51 Substance misuse 51 cognitive enhancer 51 ginkgo extract 51 theoretical frameworks 51 Cognitive Behavioral Therapy 51 postoperative infections 51 professionals HCPs 51 PREZISTA r 51 NNT = 51 medically unexplained 51 topiramate Topamax 51 corticosteroid injections 50 neurologic abnormalities 50 validating biomarkers 50 EMPOWER TM 50 GFCF diet 50 oncologists radiation oncologists 50 Ginkgo extract 50 socioeconomic inequalities 50 interventional therapies 50 antiangiogenic therapy 50 antimicrobial prophylaxis 50 nonpsychiatric 50 pathophysiological mechanisms 50 cardioprotection 50 HEDIS R 50 Multivariate logistic regression 50 subspecialist 50 prophylactic cranial irradiation 50 homoeopathic medicines 50 thrombolytic agents 50 depot antipsychotics 50 Therapeutic hypothermia 50 kidney urologic 50 novel topical reformulations 50 chlamydial infection 50 androgen excess 50 Menstrual cramps 50 CellCept mycophenolate mofetil 50 topical retinoids 50 Glucosamine chondroitin Arthritis 50 rote memorisation 50 physician assistants PAs 50 pharmacodynamic parameters 50 Ritalin methylphenidate 50 SIRT1 activation 50 coexisting illnesses 50 antihypertensive agents 50 Cognitive Behavioral Therapy CBT 50 AMOR IPAT 50 pharmacologic therapy 50 angiotensin receptor blockers 50 biofeedback therapy 50 stimulate neurogenesis 50 magnesium supplementation 50 explanatory variables 50 difficulty swallowing tablets 50 therapeutic modalities 50 ergot alkaloids 50 behaviorial 50 molecular determinants 50 prosocial behavior 50 cortisone creams 50 phosphodiesterase inhibitors 50 parasomnias 50 mTOR inhibitors 50 Limbrel 50 venous thromboembolic disease 50 pharmacologic stress 50 Complementary Alternative 50 Muscle relaxants 50 thiazide diuretics 50 Spiriva HandiHaler 50 Skincare News.com 50 Multiple linear regression 50 Uncontrolled hypertension 50 tomato lycopene 50 reboxetine 50 symptomatic hyponatremia 50 Overactive bladder 50 Epidemiologic studies 50 chlamydial infections 50 ß blockers 50 velafermin 50 neuroanatomical 50 postdischarge 50 etiologies 50 suicide ideation 50 HBV vaccination 50 LDL cholesterol lowering 50 neurosensory 50 Aggrastat ® tirofiban hydrochloride 50 chronic Lyme 50 LifeSkills Training 50 addition Exponent evaluates 50 neuro psychiatric disorders 50 Artemisinin Combination Therapies ACTs 50 acid suppressing 50 omeprazole Prilosec 50 didactic lectures 50 Surgical excision 50 biotechnological advances 50 Atypical antipsychotics 50 dysfunctional voiding 50 antifungal therapy 50 Antibacterial soap 50 randomized controlled trials 50 nongenetic 50 neuro developmental disorders 50 bio identicals 50 BodyLogicMD physicians 50 prenatal phthalate exposure 50 spinal manipulations 50 BoNTA 50 HHAs 50 radicular pain 50 tumor subtypes 50 CPT coding 50 macrolide antibiotics 50 RxNorm 50 prenatal multivitamin 50 vi ineffectiveness 50 gainsharing 50 microbiomes 50 caregiver burnout 50 antihypertensive therapy 50 ICD implantation 50 Animi 3 50 periodontal infection 50 undruggable targets 50 prenatally diagnosed 50 Dr. Cliby 50 Antibiotic resistant infections 50 Inhaled corticosteroids 50 severe hepatic dysfunction 50 CYP#A# inhibitors 50 direct thrombin inhibitors 50 recurrent UTIs 50 urinary incontinence UI 50 stratifying patients 50 adjuvant endocrine 50 aspirin clopidogrel 50 acetaminophen paracetamol 50 pharmacoeconomics 50 hyperactivity inattention 50 probiotic supplements 50 KRAS status 50 linear pharmacokinetics 50 Respiratory Therapists 50 Colloidal silver 50 urinary tract infections UTIs 50 coronary revascularization procedures 50 pharmacologic therapies 50 Nutritional supplementation 50 Mindfulness Based Cognitive Therapy 50 authors hypothesized 50 Androgen deprivation therapy 50 noncardiac chest pain 50 therapists dieticians 50 co trimoxazole prophylaxis 50 eczema asthma 50 tamoxifen raloxifene 50 CPAP adherence 50 atopic eczema 50 QOPI 50 visit www.tia.org 50 secondary amenorrhea 50 Cognitive impairment 50 dementing illnesses 50 Antidepressant medications 50 glycoprotein IIb IIIa inhibitors 50 neurobiological mechanisms 50 adjunctive therapies 50 depression schizophrenia bipolar 50 psychologists dietitians 50 opiate dependence 50 psychodynamic psychotherapy 50 oral prednisolone 50 Guaifenesin 50 perfusion CT 50 Bcr Abl mutations 50 Erythropoiesis stimulating agents 50 naturopathic treatments 50 probiotic strains 50 recurrent venous thromboembolism 50 antiarrhythmic drug 50 iron chelation 50 premenstrual symptoms 50 affective disorders 50 Functional foods 50 BARI 2D 50 journal Psychological Bulletin 50 symptom flare ups 50 clevidipine 50 hormonal therapies 50 perceptual biases 50 non ulcer dyspepsia 50 cefepime 50 neuroleptics 50 NeuroStar TMS Therapy 50 Neurostar 50 pegylated IFN 50 EquiTrend ® 50 PDE 5i 50 CoQ# supplementation 50 radiochemotherapy 50 INVEGA ® SUSTENNA TM 50 osteoporotic vertebral fractures 50 diagnostic modality 50 craniosacral therapy 50 diagnosable mental disorders 50 stone formers 50 pediatric GERD 50 living ADLs 50 rheumatologic 50 MBCT 50 medication regimens 50 Computed Tomography CT scans 50 nonembryonic stem cells 50 long acting bronchodilator 50 CRBSIs 50 bioidentical hormone 50 anticonvulsants 50 thrombophilia 50 aetiology 50 Szeinbach 50 conjugate pneumococcal vaccine 50 Topical treatments 50 antiinflammatory drugs 50 OAB symptoms 50 postoperative atrial fibrillation 50 containing LABAs 50 periodically reassessed 50 Personalised medicine 50 steroid nasal sprays 50 herb black cohosh 50 polycystic ovarian syndrome PCOS 50 Dietary calcium 50 speedier diagnosing 50 multimodality therapy 50 erection hardness 50 antibiotic regimens 50 healing modality 50 acute subacute 50 cannabis induced psychosis 50 β blockers 50 postmenopausal hormone therapy 50 insulin analogs 50 vulvovaginal atrophy 50 Bach Flower Remedies 50 BPS IC 50 cardioprotective effects 50 biochemical profiling 50 bronchopulmonary dysplasia BPD 50 impulsive behaviors 50 gonococcal infections 50 eosinophilic disorders 50 pediatric endocrinologists 50 anticonvulsant medication 50 dermatologic disorders 50 Psychometric tests 50 SDIs 50 chromium picolinate supplementation 50 chemoprevention trials 50 nosology 50 antidiabetic medication 50 TNF alpha antagonist 50 prognostic indicators 50 immunoregulation 50 ALI ARDS 50 KIF6 carriers 50 ambulatory settings 50 gynecological malignancies 50 Randomized clinical trials 50 Dr. Sharonne Hayes 50 iron chelators 50 treating neuropathic pain 50 Okunieff 50 inhibit platelet function 50 HMOS 50 AutoloGel tm 50 sideeffects 50 thiazide 50 anticancer treatments 50 osteoarthritis rheumatoid arthritis 50 menstrual disorders 50 nutritional supplementation 50 Advil ibuprofen 50 KL4 surfactant 50 Dulcolax R 50 medicalisation 50 SRBD 50 NBCR risks 50 LYSTEDA 50 microtubule targeting 50 pix Hacking 50 mosquito repellents containing DEET 50 SSRI SNRI 50 fluoxetine paroxetine 50 Adverse effects 50 clomipramine 50 orofacial clefts 50 pediatrics geriatrics 50 atherosclerotic renal artery stenosis 49 antioxidant supplements 49 secretory diarrhea 49 sedating antihistamines 49 CART peptides 49 transdermal estrogen 49 psychiatric comorbidity 49 carotid plaques 49 hormonal abnormalities 49 medicalising 49 obstructive sleep 49 monofocal 49 antiepileptic drugs AEDs 49 Antioxidant supplements 49 H2 receptor antagonists 49 LDL lowering 49 iodated salt 49 newer atypical antipsychotic 49 fetal oxygen saturation 49 macrovascular events 49 SSRI antidepressant 49 recurrent urinary tract infections